In the coming months, as the WTO decides how to proceed with this controversial decision, they must consider not just the current pandemic but the future of pharmaceutical innovations.
"I told them on the phone that [the Publix narrative] was false. And then they say that it's not that we 'ignored their perspective.' Really? Where is the balance in the story?" Moskowitz asked.